Avinger, Inc. (AVGR)

Market Cap	6.09M
Revenue (ttm)	7.62M
Net Income (ttm)	-16.13M
Shares Out	1.70M
EPS (ttm)	-16.09
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	6,056
Open	3.650
Previous Close	3.630
Day's Range	3.457 - 3.650
52-Week Range	2.500 - 18.000
Beta	1.22
Analysts	Strong Buy
Price Target	5.00 (+39.67%)
Earnings Date	May 15, 2024

About AVGR

Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) primarily in the United States and Germany. The company develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures. Its lumivascular products comprise Lightbox imaging consoles; the O...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• IPO Date: Jan 30, 2015
• Employees: 68
• Stock Exchange: NASDAQ
• Ticker Symbol: AVGR

Financial Performance

In 2023, Avinger's revenue was $7.65 million, a decrease of -7.51% compared to the previous year's $8.27 million. Losses were -$18.32 million, -32.76% less than in 2022.

Analyst Forecast

According to one analyst, the rating for AVGR stock is "Strong Buy" and the 12-month stock price forecast is $5.0.

Price Target

$5.0

(39.67% upside)

Analyst Consensus: Strong Buy